introduction to ros in the cardiovascular system john f. keaney, jr., m.d. umass medical school...

31
Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Upload: leo-owens

Post on 13-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Introduction to ROS inthe Cardiovascular System

John F. Keaney, Jr., M.D.UMass Medical School

Worcester, MA

Page 2: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Role of ROS in CV Disease: Antiquated

NEJM, 1997

Page 3: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Homeostasis

Endogenous Sources

MitochondriaPeroxisomesLipoxygenasesNADPH OxidasesCytochrome P450

AntioxidantDefenses

Enzymatic Systems: CAT, SOD, GPXNon-enzymatic systems: Glutathione Vitamins

Impaired PhysiologicFunction

Impaired PhysiologicFunction

NormalDecreased Repair

Decreased Adaptive Responses

Random Oxidation

Specific SignalPathways

Vascular and MyocardialDisease

Vascular and MyocardialDisease

ROS/RNS

Adapted from Finkel and Holbrook, 2007

Page 4: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidases

Neutrophil “Burst” Oxidase NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 5: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Contemporary ROS and CV System:Major Areas of Influence

Cardiac FunctionHypertrophy

AtherosclerosisHypertension

AngiogenesisVascular Repair

Page 6: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Contemporary ROS and CV System:Major Areas of Influence

Cardiac FunctionHypertrophy

AtherosclerosisHypertension

AngiogenesisVascular Repair

Page 7: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 8: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Nox2 Influences Cardiac RemodelingAfter Myocardial Infarction

Hypertension. 2008 Feb;51(2):319-25

• Less pathologic heart remodeling

• Reduced change to the fetal gene program

• Less apoptosis

Page 9: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 10: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Trans Aortic Constriction Model

AorticSuture

WT TAC

Page 11: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Cardiac Nox4 is Deleterious in Pressure Overload

Kuroda J et al. PNAS 2010;107:15565-15570

• Less pathologic hypertrophy

• Improved function (ejection fraction)

• Less apoptosis

Page 12: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Nox4 Impacts Multiple ROS Sources

Kuroda J et al. PNAS 2010;107:15565-15570

Page 13: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Interaction of ROS Sources

Cave et. al. Antioxid. Redox Signal. 8, 691–728

Page 14: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Contemporary ROS and CV System:Major Areas of Influence

Cardiac FunctionHypertrophy

AtherosclerosisHypertension

AngiogenesisVascular Repair

Page 15: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 16: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase Activity and Atherosclerosis

• ApoE(-/-) mice with or without p47phox

• Animals on chow followed for 30 weeks

• ROS production measured by DHE staining

• Atherosclerosis determined by aortic lipid content

Barry-Lane et al. J. Clin. Invest. 2001;108:1513

0

50

100

150

RO

SF

lux

(+/+) (-/-)

p47Phox Status

0

2

4

6

Les

ion

(mm

2)

(+/+) (-/-)

p47Phox Status

*

*

*P<0.05

Page 17: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

What about hypertension?

Page 18: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Renin-Angiotensin System

Page 19: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 20: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Nox2 and Hypertension

Landmesser, U. et al. Hypertension 2002;40:511-515

• Less ROS produced from blood vessels

• Less rise in blood pressure

• Less vascular hypertrophy

Page 21: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Not all ROS sources are equal!

Page 22: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 23: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

BP and Hypertrophy are Distinct

Matsuno, K. et al. Circulation 2005;112:2677-2685

Ang II Infusion

Page 24: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Contemporary ROS and CV System:Major Areas of Influence

Cardiac FunctionHypertrophy

AtherosclerosisHypertension

AngiogenesisVascular Repair

Page 25: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

NADPH Oxidase (Nox) Enzyme Family

Bedard and Krause, Physiol. Rev. 2007;87

Page 26: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Bone Marrow Nox2 is Important for Ischemia-Induced Angiogenesis

Urao, N. et al. Circ Res 2008;103:212-220

• Lack of Nox2 impairs ischemia-induced angiogenesis

• This effect is most prominent in bone marrow

Page 27: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Chen et al., PNAS 2004;101:13014-13019

Nox2 Modifies Arterial Injury

IEL

Wild-type, 28d

IEL

Nox2-/- , 28d

Intima:Media

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

39%P=0.036

WT Nox2-/-

Page 28: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

How about other ROS Sources?

Page 29: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Mitochondrial ROS are Important for Hypoxic Responses

Guzy et al. , Cell Metabolism, 2005

b

b b

Page 30: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

Take Home Points

• ROS are ubiquitous, and serve as cellular messengers

• ROS responses are generally linked to injury and repair responses

• ROS sources and the regulation of these sources has, thus far, proven the most fruitful means of impacting disease

• NADPH oxidases are one important source of ROS in the cardiovascular system

Page 31: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA

What we do not yet know

• Which source(s) of ROS are specific for certain pathologic disorders

• How do the different source(s) of ROS relate to each other

• What are the “normal” mechanisms for specificity of ROS species

• Which ROS/RNS are most important in specific disease(s)